Angioblast Systems therapeutic programs, adult stem cells, repair, regeneration of blood vessels, adult stem cells technology, cardiovascular disease,



	**JavaScript based drop down DHTML menu generated by Visual QuickMenu Pro. (OpenCube Inc. - http://www.opencube.com)** Home Technology Overview FAQ Allogeneic Adult Stem Cells Protein Therapeutics Gene Silencing Applications Overview Heart Attack Congestive Heart Failure Peripheral Artery Disease Wound Ulcers Key Scientific Terms Adult Stem Cells Protein Therapeutics Gene Silencing Product Development Overview MPC Mesoblast Device Companies Clinical Network Management Board SAB News & Press Releases Publications Contact

	News
	9 April 2010 - ANGIOBLAST’S MARKET EXCLUSIVITY FOR ITS BIOLOGIC PRODUCTS STRENGTHENED BY NEW UNITED STATES HEALTH CARE ACT 18 December 2009 - SINGLE DOSE OF PROPRIETARY ADULT STEM CELLS REGENERATES DAMAGED PANCREAS AND REDUCES BLOOD GUCOSE LEVELS IN DIABETES 18 November 2009 - SUSTAINED SIX-MONTH IMPORVEMENT IN HEART MUSCLE FUNCTION BY “OFF-THE-SHELF” ADULT STEM CELLS 06 November 2009 - SUCCESSFUL BONE MARROW REGENERATION IN CANCER PATIENTS USING CORD BLOOD EXPANDED BY PROPRIETARY STEM CELLS 25 August 2009 - ANGIOBLAST CLOSES $10M EQUITY-BASED FINANCINGANGIOBLAST CLOSES $10M EQUITY-BASED FINANCING		Therapeutic Programs and Products Product Development Overview MPC